In the BioHarmony Drug Report Database

"Preview" Icon

Ergotamine tartrate

Medihaler Ergotamine (ergotamine tartrate) is a small molecule pharmaceutical. Ergotamine tartrate was first approved as Medihaler Ergotamine on 1982-01-01. It is used to treat cluster headache, migraine disorders, and postpartum hemorrhage in the USA. It is known to target 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2C, and 5-hydroxytryptamine receptor 2A.

 

Trade Name

 

Medihaler Ergotamine
 

Common Name

 

ergotamine tartrate
 

ChEMBL ID

 

CHEMBL2448612
 

Indication

 

cluster headache, migraine disorders, postpartum hemorrhage
 

Drug Class

 

Image (chem structure or protein)

Ergotamine tartrate structure rendering